NUTRA PHARMA CORP
AI Executive Summary
AI-powered analysis of 10-K filing content
Nutra Pharma presents significant red flags including a suspicious future filing date of December 31, 2025, incomplete filing content that repeats table of contents across multiple sections, and appears to be a small biopharmaceutical company with limited commercial success despite 20+ years in operation. The company has shifted from its original business model (Exotic-Bird.com) to pain relief products but shows signs of financial distress.
Red Flags Detected (7)
Filing dated for future year 2025 instead of historical period
Incomplete 10-K with repetitive table of contents instead of actual section content
Original incorporation as 'Exotic-Bird.com' suggests questionable business origins
4 more red flags detected
Key Takeaways
Filing appears incomplete or erroneous with future date of December 31, 2025
Company has been operating since 2003 but shows limited growth with basic OTC product line
2 more takeaways
Filing Overview
What This Means
High Risk Filing: This company is showing signs of financial stress or significant operational challenges.
Deteriorating Trend: Conditions are worsening compared to previous filings. This may create opportunities for service providers.
Annual Report: Comprehensive filing covering the full fiscal year with audited financial statements.